- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03241212
Adolescent Self-Care and Knowledge Education in Diabetes--Improved by Texting (ASKED-IT)
Adolescent Self-Care and Knowledge Education in Diabetes--Improved by Texting (ASKED-IT)
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 800045
- Barbara Davis Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of type 1 diabetes mellitus
- Receiving care in the pediatric clinic at the Barbara Davis Center (BDC)
- Age 15-20 at study enrollment
- English literate and English speaking
- Ability to complete the required surveys
- Have a personal cell phone with service compatible with EZTexting Platform
- Able to provide informed assent or consent (if 18 years of age or older) and parental informed consent (if needed).
Exclusion Criteria:
- Not planning to continue care in the pediatric clinic at BDC for at least the next 6 months.
- Diabetes Diagnosis other than Type 1 Diabetes
- Inability for the adolescent to respond to text messages (e.g. due to developmental delay)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
At baseline enrollment: participants will be asked to fill out a demographic survey, the MWIKAD survey and the SMOD-A survey. HbA1c, frequency of Blood Glucose (BG) checks and percent of glucose values above, within and below the target range will be extracted from chart review. Surveys (with the exception of demographics) and chart extraction will be repeated at 3 months and 6 months post enrollment. |
|
|
Experimental: Texting
Participants will be asked to complete the same surveys on the same timeline as above. The texting group will be asked to provide their cell phone number to the texting software. From baseline appointment to 26 weeks post enrollment, participants will receive a text message every Monday, Wednesday and Friday. Some text messages will be informational only, others will ask the participant for a response to a multiple-choice question with immediate feedback on the answer chosen. |
From baseline appointment to 6 month follow up, those participants randomly assigned to the texting intervention will receive a text message every Monday, Wednesday and Friday.
Some text messages will be informational only, others will ask the participant for a response to a multiple-choice question with immediate feedback on the answer chosen.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in knowledge about type 1 diabetes
Time Frame: 6 months from intervention
|
Measured by the Mercy-What I Know About Diabetes Test (MWIKAD)
|
6 months from intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in diabetes self-care practices
Time Frame: at 3 months and 6 months
|
Assessed by the Self-Management of Type 1 Diabetes in Adolescents (SMOD-A) tool
|
at 3 months and 6 months
|
|
Change in Hemoglobin A1c
Time Frame: at 3 months and 6 months
|
at 3 months and 6 months
|
|
|
Change in blood glucose testing frequency
Time Frame: at 3 months and 6 months
|
at 3 months and 6 months
|
|
|
Change in percent of blood glucoses high, in range and low
Time Frame: at 3 months and 6 months
|
at 3 months and 6 months
|
|
|
Percent of text messages responded to in the study.
Time Frame: After 6 months of texting intervention
|
After 6 months of texting intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sonalee Ravi, MD, University of Colorado, Denver
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-1135
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes Mellitus
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Sultan Qaboos UniversityUniversity of Mosul; University of Child Health Sciences and Children's Hospital...Not yet recruitingType 1 Diabetes Mellitus | T1DM | Type 1 Diabetes Mellitus (T1DM) | T1DM - Type 1 Diabetes Mellitus
-
Lund UniversityEnrolling by invitationType 1 Diabetes Mellitus | Stage 2 Type 1 Diabetes | Stage 1 Type 1 Diabetes | Stage 3 Type 1 DiabetesSweden
-
Superior UniversityActive, not recruitingType 2 Diabetes Mellitus 1Pakistan
-
Abdullah KarsNot yet recruitingType 1 Diabetes Mellitus | Autoimmune Diabetes | Type 1 Diabetes Mellitus (T1DM)Turkey (Türkiye)
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Immunocore LtdNot yet recruitingType 1 Diabetes | Diabetes Type 1 | Type 1 Diabetes (T1D)
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Al-Zaytoonah University of JordanActive, not recruitingType 1 Diabetes | Type 1 Diabetes MellitusEgypt
Clinical Trials on Texting
-
St. Louis UniversityCompletedSMS | Education, Medical, UndergraduateUnited States
-
University of MichiganNational Institute of Mental Health (NIMH)Completed
-
University of PennsylvaniaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedEarly Pregnancy | Early Pregnancy LossUnited States
-
Northwestern UniversityCompletedGestational Diabetes | Pregnancy in Diabetics
-
General Committee of Teaching Hospitals and Institutes...King Saud UniversityCompletedMuscle Weakness Condition | Hand GraspSaudi Arabia
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; Leonard Davis Institute of Health EconomicsCompletedParent-Child Relations | Parenting | LiteracyUnited States
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
University of Illinois at Urbana-ChampaignUniversity of Minnesota; The University of The West IndiesCompleted
-
University of WashingtonCompleted